This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Respiratory
Inhaled combination treatment shows significant improvements over current standard-of-care
Read more
First patients for UK ‘chronic pain’ trial
Read more
Expert analysis: The importance of confirming allergic triggers in rhinitis
Read more
Bronchiectasis associated with high frequency of allergy
Read more
Dupilumab label expanded for severe asthma indication
Read more
Allergen immunotherapy shows positive effects in the nasal membrane
Read more
Patients aged 18-29 receive worst asthma care in UK, charity reveals
Read more
European Commission approval for self-administration of Xolair® across all indications
Read more
Most accurate tool yet developed to predict asthma in young children
Read more
Research shows that environmental exposures early in life modify immune responses
Read more
Test predicts outcomes of hay fever therapies
Read more
Government should consider economic as well as health benefits of flu vaccinations, says think tank
Read more
Steering Group calls for action in fighting influenza
Read more
Plans to commercialise novel cell-based quadrivalent influenza vaccine in Europe
Read more
First once-daily single inhaler triple therapy to be approved in Europe
Read more
Once-daily single inhaler triple therapy receives positive opinion for appropriate patients with COPD
Read more
Results of Phase III CONVERT study of ALIS in treatment-refractory NTM lung disease announced
Read more
Page 10 of 12
« First
«
...
8
9
10
11
12
»
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Biomarker and MRI-enhanced strategies comparable for prostate cancer screening, study finds
26 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
x
Search for: